-+ 0.00%
-+ 0.00%
-+ 0.00%

Have Editas Medicine Insiders Been Selling Stock?

Simply Wall St·11/15/2026 13:27:10
Listen to the news

Investors may wish to note that the President of Editas Medicine, Inc., Gilmore O’Neill, recently netted US$51k from selling stock, receiving an average price of US$2.42. However we note that the sale only shrunk their holding by 9.1%.

The Last 12 Months Of Insider Transactions At Editas Medicine

Notably, that recent sale by Gilmore O’Neill is the biggest insider sale of Editas Medicine shares that we've seen in the last year. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$2.17). So it may not shed much light on insider confidence at current levels.

In the last year Editas Medicine insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

View our latest analysis for Editas Medicine

insider-trading-volume
NasdaqGS:EDIT Insider Trading Volume November 15th 2026

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Does Editas Medicine Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data isn't picking up on much insider ownership at Editas Medicine, though insiders do hold about US$809k worth of shares. We might be missing something but that seems like very low insider ownership.

So What Does This Data Suggest About Editas Medicine Insiders?

Insiders sold Editas Medicine shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. Insiders own relatively few shares in the company, and when you consider the sales, we're not particularly excited about the stock. So we're not rushing to buy, to say the least. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To help with this, we've discovered 5 warning signs (2 shouldn't be ignored!) that you ought to be aware of before buying any shares in Editas Medicine.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.